-
Arena Pharmaceuticals Inc. et al v. Lupin Ltd. et al DC
- 1:16-cv-00887
- D. Del.
- Judge: Richard G. Andrews
- Filed: 09/30/2016
- Closed: 04/04/2019
- Latest Docket Entry: 04/16/2019
- PACER
- Docket updated daily
4
Plaintiffs
3
Defendants
1
Accused
Product
6
Patents-in-Suit
917
Days in
Litigation
-
Arena Pharmaceuticals Inc. et al v. Lupin Ltd. et al DC
- 1:16-cv-00887
- D. Del.
- Judge: Richard G. Andrews
- Filed: 09/30/2016
- Closed: 04/04/2019
- Latest Docket Entry: 04/16/2019
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Lupin Limited
- 6 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg of lorcaserin hydrochloride tablets | US 6,953,787 B2 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 7,514,422 B2 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 7,977,329 B2 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 8,207,158 B2 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 8,273,734 B1 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 9,770,455 B2 | All Asserted Claims |
Infringement
Entry 155
|
Lupin Pharmaceuticals Incorporated
- 6 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg of lorcaserin hydrochloride tablets | US 6,953,787 B2 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 7,514,422 B2 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 7,977,329 B2 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 8,207,158 B2 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 8,273,734 B1 | All Asserted Claims |
Infringement
Entry 155
|
| 10 mg of lorcaserin hydrochloride tablets | US 9,770,455 B2 | All Asserted Claims |
Infringement
Entry 155
|
Teva Pharmaceuticals USA, Inc.
- 6 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg of lorcaserin hydrochloride tablets | US 6,953,787 B2 | All Asserted Claims |
Infringement
Entry 142
|
| 10 mg of lorcaserin hydrochloride tablets | US 7,514,422 B2 | All Asserted Claims |
Infringement
Entry 142
|
| 10 mg of lorcaserin hydrochloride tablets | US 7,977,329 B2 | All Asserted Claims |
Infringement
Entry 142
|
| 10 mg of lorcaserin hydrochloride tablets | US 8,207,158 B2 | All Asserted Claims |
Infringement
Entry 142
|
| 10 mg of lorcaserin hydrochloride tablets | US 8,273,734 B1 | All Asserted Claims |
Infringement
Entry 142
|
| 10 mg of lorcaserin hydrochloride tablets | US 9,770,455 B2 | All Asserted Claims |
Infringement
Entry 142
|
